MB and rhabdomyolysis: The study by Jerman et al. [66] compared the use of HCO and medium cut off (MCO) dialysis membranes and cytokine adsorbers (CytoSorb®) in patients with AKI stage 2–3 according to KDIGO and rhabdomyolysis with myoglobin levels >20,000 μg/L.